Meet the fellows

Meet the Lupus Ontario Geoff Carr Fellows!

30+ fellows & counting

30+ Years of the Lupus Ontario Geoff Carr Fellowship means, 30+ years of lupus research by our amazing fellows! Learn more about them below.

Fellow Spotlight!

Dr. Amanda Steiman

Assistant Professor, Rheumatologist at Sinai Health/University Health Network, Toronto

Dr. Amanda Steiman received the Fellowship in 2011.  She is currently a staff rheumatologist at Sinai Health/University Health Network in Toronto, and an Assistant Professor of Medicine at the University of Toronto. Her clinical niche continues to be lupus, and she has developed a Young Adult SLE Clinic, in collaboration with pediatric rheumatologist/lupologist, Dr. Earl Silverman.  Her academic interest is in Quality Improvement, and she continues to be involved in lupus research in this domain. 

 

Dr. Steiman states,

 ‘The Geoff Carr Fellowship was invaluable to my current clinical and research activities, allowing me to hone my lupus acumen and develop my clinical and research foci, as above.  It allowed me to work with world leaders in the field of lupus (Drs. Gladman and Urowitz). 

Dr. Zahi Touma

Assistant Professor of Medicine, University of Toronto; Clinician Scientist, Krembil Research Institute

Dr.  Zahi Touma was awarded the Fellowship in 2008 and 2010.  He came to Canada from Lebanon.  After his Fellowship years Dr. Touma stayed on as a Clinician-Scientist, Rheumatology, University Health Network.  He continues to perform lupus research.  He has completed many research projects.

Some of the key ones are:

  • Improving the assessment of lupus disease activity – this resulted in the validation of SLEDAI-2K 30 days against 10 days; and the development of S2K RI-50 to measure partial improvement in disease activity
    Development of a new tool to account for the dose of prednisone when assessing disease activity – SLEDAI 2KG
  • Validation of ANAM to facilitate cognitive function test in SLE patients
  • Studying the role of LupusQoL – an SLE specific quality of life questionnaire
  • Studying time to improvement of proteinuria in the management of lupus nephritis in addition to several studies focused on the prognostic value of proteinuria in term on other comorbidities (advanced chronic kidney disease, dialysis, etc.)
  • ECG changes in SLE patients.
  • Improving the assessment of anxiety and depression in SLE

Geoff Carr Fellowship Recipients

Meet all of the Lupus Ontario Geoff Carr Research fellows, and learn about their research and area of study! 
 
2021 - 2022 SickKids Hospital
Dr. Tala El Tal

Determination of the clinical subtypes of cognitive impairment in SLE patients to facilitate precision health care and better outcomes.

2020 - 2021 Toronto Western Hospital
Dr. Ambika Gupta

Determination of the clinical subtypes of cognitive impairment in SLE patients to facilitate precision health care and better outcomes.

2019 - 2020 Toronto Western Hospital
Dr. Laura Whittal Garcia

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2018 -2019 SickKids Hospital
Dr. Anita Dhanrajani

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2017-2018 Toronto Western Hospital
Dr. Konstantinos Tselios

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2016-2017 SickKids Hospital
Dr. Julie Couture

Depression in paediatric SLE patients.

2015 - 2016 Toronto Western Hospital
Dr. Jorge Medina Rosas

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2014 - 2015 Toronto Western Hospital
Dr. Konstantinos Tselios

The management of Arterial Hypertension and Hypercholesterolemia in patients with SLE. Are the current treatment guidelines adequate for lupus patients?

2013 - 2014 McMaster University
Dr. Kim Legault

Pathophysiology of cognitive dysfunction in patients with antiphospholipid antibodies and lupus.

2012 - 2013 Toronto Western Hospital
Dr. Barry Sheane

Cardio vascular risks in patients with SLE.

2011 - 2012 Toronto Western Hospital
Dr. Amanda Steiman

Predicting flares in patients who are serologically active and and clinically quiescent.

2010 - 2011
Dr. Zahi Touma

SRI-50 Index which is used to measure disease activity.

2009 - 2010 McMaster University
Dr. Derek Haaland

Lupus Nephritis.

2008 -2009 SickKids Hospital
Dr. Satish Kumar

Long term outcome of children with SLE with emphasis on the Central Nervous System 

2008 -2009 Toronto Western Hospital
Dr. Zahi Touma

Outcome measures used in clinical trials in SLE in order to find an optimal measure.

2007-2008 Toronto Western Hospital
Dr. Desiree Tulloch-Reid

Lupus Nephritis.

2006-2007
Dr. Mandana Nikpour

Atherscerlosis in SLE

2005-2006 Toronto Western Hospital
Dr. Zhaleh Shariati

Definition of thrombitis risk associated with anticardiolipin antibofy in SLE

2004-2005 Toronto Western Hospital
Dr. Mandana Nikpour

Vascular disease in systemic Lupus Erythematosus

2003-2004 SickKids Hospital
Dr. Susanne Benseler

Methods to improve paediatric Lupus treatment.

2002-2003 Toronto Lupus Clinic
Dr. Adrienne Williamson
2001-2002
Dr. Marie Feletar

Impact of the updated 1997 revised criteria for classification of SLE, Prolonged remission in SLE

2000-2001 Toronto Lupus Clinic
Dr. Dana Jerome

The effective of menopause on disease activity in SLE

1999-2000
Dr. Anna Jaroszynska

Bone mineral density in premenopausal females with SLE

1998-1999 Toronto Lupus Clinic
Dr. Santiago Aguero
1997-1998 SickKids Hospital
Dr. Stefan Hagelberg

Pathogenic mechanisms in lupus patients with CNS involvement

1996-1997 University of Toronto
Dr. Ian Bruce

Assess the prevalence of ischemic heart disease in patients with SLE, current management of risk factors for coronary artery disease

1995-1996 McMaster University
Dr. Sergio Toloza
1994-1995 The Wellesley Hospital / University of Toronto
Dr. Vandana Chaudry

Osteonecrosis in SLE

1993-1994 The Wellesley Hospital / University of Toronto
Dr. Mahmood Abu-Shakra
  • Anticardiolipin Antibodies in SLE: Clinical and Laboratory Correlations
  • The Significance of Anticardiolipin Antibodies in patients with Lupus Nephritis
1992-1993 The Wellesley Hospital / University of Toronto
Dr. Julie Kovacs

Single Photon Emission Computerized Tomography (SPECT) in Neuropsychiatric SLE

1991-1992 The Wellesley Hospital / University of Toronto
Dr. Rachel Pauzner
  • Prolactin in SLE
  • Anti-neutrophil Cytoplasmic Antibodies (ANCA) in SLE
  • Evaluation of predictive factors for neurocognitive dysfunction in patients with SLE
1990-1991 The Wellesley Hospital / University of Toronto
Dr. Barbara Walz-Leblanc

Serologically Active Clinically Quiescent Systemic Lupus Erythematosus (SLE) - Predictors of Clinical Flares